Koo ... agree that funding is a real hold back. Need some news there, if any?!

My takeaways from the release though were:

1. RVX showing some "bolder" confidence & fight overall with a more assertive message to the "world"

2. Possibly more confidence re break-through fast track - "clear path to commercilization"

3. Possibly identifying the targeted BP's in/for further discussion (Merck, Lilly/Boehringer)?? 

I agree not much "new" there, but I was intrigued with the crisp boldness, and potential clues to strategy and confidence in the strategy, and maybe even sending some messages to certain "interested/competing" BP's through tone? ... I could be a sucker being duped with "spin" though seeing what I want and hope to see also though?! Who knows, it could just be a pumping exercize, but it would seem a departure from what I've seen in the past 4-5 years, and considering the stage apabetalone is at now?

Mostly, I am hopeful that the tone and confidence relates (just a bit?) to anticipated regulatory news that should be coming within a few months.